Gold Investment Management Ltd.

Position in JNJ — Johnson & Johnson

CIK 2006008 EDMONTON, A0

Position in JNJ

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$5,051,717

+$196,161 QoQ

Shares Held

19,891

+0.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.48%

of 13F equity value

Holder Rank

#1,609

of 4,664 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Gold Investment Management Ltd. holds $14,557,675 across 12 Drug Manufacturers - General names. JNJ ranks #1 (34.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	19,891	$5,051,717
2	LLY	ELI LILLY & Co	2,391	$2,867,837
3	MRK	Merck & Co., Inc.	16,465	$2,115,752
4	ABBV	AbbVie Inc.	8,043	$2,023,940
5	PFE	Pfizer Inc	57,668	$1,388,645
6	BMY	Bristol Myers Squibb Co	12,542	$722,670
7	AMGN	Amgen Inc	945	$342,203
8	GILD	Gilead Sciences, Inc.	280	$35,375

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,051,717	19,891	+0.1%	Shares	Sole	2026-08-06
2026-03-31	$4,855,556	19,864	+1.3%	Shares	Sole	2026-04-22
2025-12-31	$4,059,531	19,616	+2.1%	Shares	Sole	2026-01-28
2025-09-30	$3,562,289	19,212	+2.2%	Shares	Sole	2025-10-29
2025-06-30	$2,870,172	18,790	+1.5%	Shares	Sole	2025-07-18
2025-03-31	$3,069,864	18,511	+6.5%	Shares	Sole	2025-04-24
2024-12-31	$2,514,797	17,389	+1.0%	Shares	Sole	2025-02-10
2024-09-30	$2,790,835	17,221	-4.5%	Shares	Sole	2024-10-31
2024-06-30	$2,635,849	18,034	-0.7%	Shares	Sole	2024-07-26
2024-03-31	$2,872,888	18,161	-4.1%	Shares	Sole	2024-05-03
2023-12-31	$2,966,774	18,928	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.